The use of incretin-based therapies in diabetes mellitus initiated the idea of a potentially beneficial role of incretins in the prevention of atherosclerosis and heart failure, mediating different signaling pathways in cardiac and vascular cells. The gene discussed is GCG; the disease is heart failure.